273 related articles for article (PubMed ID: 9574793)
1. Three probable cases of Loa loa encephalopathy following ivermectin treatment for onchocerciasis.
Boussinesq M; Gardon J; Gardon-Wendel N; Kamgno J; Ngoumou P; Chippaux JP
Am J Trop Med Hyg; 1998 Apr; 58(4):461-9. PubMed ID: 9574793
[TBL] [Abstract][Full Text] [Related]
2. Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection.
Gardon J; Gardon-Wendel N; Demanga-Ngangue ; Kamgno J; Chippaux JP; Boussinesq M
Lancet; 1997 Jul; 350(9070):18-22. PubMed ID: 9217715
[TBL] [Abstract][Full Text] [Related]
3. A Test-and-Not-Treat Strategy for Onchocerciasis in Loa loa-Endemic Areas.
Kamgno J; Pion SD; Chesnais CB; Bakalar MH; D'Ambrosio MV; Mackenzie CD; Nana-Djeunga HC; Gounoue-Kamkumo R; Njitchouang GR; Nwane P; Tchatchueng-Mbouga JB; Wanji S; Stolk WA; Fletcher DA; Klion AD; Nutman TB; Boussinesq M
N Engl J Med; 2017 Nov; 377(21):2044-2052. PubMed ID: 29116890
[TBL] [Abstract][Full Text] [Related]
4. [Retinal hemorrhages after ivermectin treatment for onchocerciasis in a patient with Loa loa microfilaremia].
Moussala M; Fobi G; Ongolo Zogo P; Bella Hiag LA; Bengono G; McMoli TE
J Fr Ophtalmol; 2004 Jan; 27(1):63-6. PubMed ID: 14968080
[TBL] [Abstract][Full Text] [Related]
5. Ivermectin in loiasis and concomitant O. volvulus and M. perstans infections.
Richard-Lenoble D; Kombila M; Rupp EA; Pappayliou ES; Gaxotte P; Nguiri C; Aziz MA
Am J Trop Med Hyg; 1988 Nov; 39(5):480-3. PubMed ID: 3195695
[TBL] [Abstract][Full Text] [Related]
6. [Secondary effects of the treatment of hypermicrofilaremic loiasis using ivermectin].
Ducorps M; Gardon-Wendel N; Ranque S; Ndong W; Boussinesq M; Gardon J; Schneider D; Chippaux JP
Bull Soc Pathol Exot; 1995; 88(3):105-12. PubMed ID: 8555762
[TBL] [Abstract][Full Text] [Related]
7. Macrofilaricidal activity after doxycycline only treatment of Onchocerca volvulus in an area of Loa loa co-endemicity: a randomized controlled trial.
Turner JD; Tendongfor N; Esum M; Johnston KL; Langley RS; Ford L; Faragher B; Specht S; Mand S; Hoerauf A; Enyong P; Wanji S; Taylor MJ
PLoS Negl Trop Dis; 2010 Apr; 4(4):e660. PubMed ID: 20405054
[TBL] [Abstract][Full Text] [Related]
8. Satellite mapping of Loa loa prevalence in relation to ivermectin use in west and central Africa.
Thomson MC; Obsomer V; Dunne M; Connor SJ; Molyneux DH
Lancet; 2000 Sep; 356(9235):1077-8. PubMed ID: 11009145
[TBL] [Abstract][Full Text] [Related]
9. Encephalopathy after ivermectin treatment in a patient infected with Loa loa and Plasmodium spp.
Kamgno J; Boussinesq M; Labrousse F; Nkegoum B; Thylefors BI; Mackenzie CD
Am J Trop Med Hyg; 2008 Apr; 78(4):546-51. PubMed ID: 18385346
[TBL] [Abstract][Full Text] [Related]
10. Implications for annual retesting after a test-and-not-treat strategy for onchocerciasis elimination in areas co-endemic with Loa loa infection: an observational cohort study.
Pion SD; Nana-Djeunga H; Niamsi-Emalio Y; Chesnais CB; Deléglise H; Mackenzie C; Stolk W; Fletcher DA; Klion AD; Nutman TB; Boussinesq M; Kamgno J
Lancet Infect Dis; 2020 Jan; 20(1):102-109. PubMed ID: 31676244
[TBL] [Abstract][Full Text] [Related]
11. Co-endemicity of loiasis and onchocerciasis in rain forest communities in southwestern Nigeria.
Ojurongbe O; Akindele AA; Adeleke MA; Oyedeji MO; Adedokun SA; Ojo JF; Akinleye CA; Bolaji OS; Adefioye OA; Adeyeba OA
PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003633. PubMed ID: 25812086
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the mdr-1 gene in patients co-infected with Onchocerca volvulus and Loa loa who experienced a post-ivermectin serious adverse event.
Bourguinat C; Kamgno J; Boussinesq M; Mackenzie CD; Prichard RK; Geary TG
Am J Trop Med Hyg; 2010 Jul; 83(1):28-32. PubMed ID: 20595473
[TBL] [Abstract][Full Text] [Related]
13. Projected Number of People With Onchocerciasis-Loiasis Coinfection in Africa, 1995 to 2025.
Vinkeles Melchers NVS; Coffeng LE; Boussinesq M; Pedrique B; Pion SDS; Tekle AH; Zouré HGM; Wanji S; Remme JH; Stolk WA
Clin Infect Dis; 2020 May; 70(11):2281-2289. PubMed ID: 31304961
[TBL] [Abstract][Full Text] [Related]
14. [The efficacy and tolerance of ivermectin (Mectizan) prescribed for the patient with multiple filarial infections (Loa loa/Onchocerca and/or M. perstans)].
Richard-Lenoble D; Kombila M; Chandenier J; Gaxotte P
Bull Soc Pathol Exot Filiales; 1989 Jan; 82(1):65-71. PubMed ID: 2743519
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of the prevention of post-ivermectin Loa loa encephalopathy by administration of initial low dose].
Kamgno J; Gardon J; Boussinesq M
Med Trop (Mars); 2000; 60(3):275-7. PubMed ID: 11258063
[TBL] [Abstract][Full Text] [Related]
16. Rapid assessment method for prevalence and intensity of Loa loa infection.
Takougang I; Meremikwu M; Wandji S; Yenshu EV; Aripko B; Lamlenn SB; Eka BL; Enyong P; Meli J; Kale O; Remme JH
Bull World Health Organ; 2002; 80(11):852-8. PubMed ID: 12481206
[TBL] [Abstract][Full Text] [Related]
17. Microfilarial distribution of Loa loa in the human host: population dynamics and epidemiological implications.
Pion SD; Filipe JA; Kamgno J; Gardon J; Basáñez MG; Boussinesq M
Parasitology; 2006 Jul; 133(Pt 1):101-9. PubMed ID: 16764737
[TBL] [Abstract][Full Text] [Related]
18. Variation in incidence of serious adverse events after onchocerciasis treatment with ivermectin in areas of Cameroon co-endemic for loiasis.
Twum-Danso NA; Meredith SE
Trop Med Int Health; 2003 Sep; 8(9):820-31. PubMed ID: 12950668
[TBL] [Abstract][Full Text] [Related]
19. Case Report: Probable Case of Spontaneous Encephalopathy Due to Loiasis and Dramatic Reduction of
Arrey-Agbor DB; Nana-Djeunga HC; Mogoung-Wafo AE; Mafo M; Danwe C; Kamgno J
Am J Trop Med Hyg; 2018 Jul; 99(1):112-115. PubMed ID: 29741149
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of an Onchocerca ochengi microfilarial hamster model for onchocerciasis drug screens.
Mbah GE; Ayiseh RB; Cho-Ngwa F
BMC Infect Dis; 2016 Aug; 16(1):404. PubMed ID: 27515037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
